Pemazil tablets 4.5mg

Pemazil tablets 4.5mg, manufactured by Insight Biosciences Japan, contains Pemigatinib (YJ code: 4291072F1024, standard: 4.5 mg 1 tablet). This kinase inhibitor works by blocking fibroblast growth factor receptors (FGFR1, FGFR2, and FGFR3), which are involved in the growth and spread of cancer cells. It is primarily used for certain types of bile duct cancer (cholangiocarcinoma) and myeloid/lymphoid neoplasms with FGFR rearrangements.